Association between elevated body mass index and new-onset heart failure in patients undergoing catheter ablation for atrial fibrillation
Background Atrial fibrillation (AF) is the most common arrhythmia and a major contributor to heart failure (HF). While catheter ablation (CA) reduces HF progression, some patients remain at risk for incident HF after ablation. This study aims to analyze the relationship between body mass index (BMI) and new-onset HF in patients undergoing CA for AF. Methods We retrospectively studied patients from the MGH Research Patient Data Registry who underwent first-time CA for AF from January 2013 to August 2024. The primary outcome was new-onset HF. Cox regression identified independent predictors, and Kaplan–Meier analysis assessed HF-free survival across BMI categories. Results Among 7,363 patients, 550 (7.5%) developed HF during 3.6 ± 2.9 years of follow-up. HF-free survival declined across increasing BMI categories. At 10 years, HF-free survival was 94.2% for BMI <25 and 86.3% for BMI ≥40. Independent predictors of HF included age ≥75 years (HR 1.79, 95% CI 1.45–2.22), female sex (HR 1.41, 95% CI 1.16–1.73), hypertension (HR 1.28, 95% CI 1.03–1.59), ischemic heart disease (HR 1.44, 95% CI 1.19–1.74), mitral regurgitation (HR 2.60, 95% CI 2.07–3.27), aortic stenosis (HR 1.97, 95% CI 1.38–2.80), pulmonary hypertension (HR 3.02, 95% CI 2.26–4.05), pulmonary embolism (HR 1.99, 95% CI 1.23–3.21), eGFR <60 (HR 2.51, 95% CI 1.87–3.37), BMI 30–34.99 (HR 1.41, 95% CI 1.08–1.85), BMI 35–39.99 (HR 1.90, 95% CI 1.38–2.62), and BMI ≥40 (HR 2.31, 95% CI 1.56–3.41). Conclusions Elevated BMI is independently associated with new-onset HF after AF ablation, with risk rising progressively across BMI categories. These patients may warrant continued attention to cardiovascular risk after ablation.
Authors
- Jeremy N. Ruskin (ORCID: https://orcid.org/0000-0001-7048-4328)
- Mohamed Doma (ORCID: https://orcid.org/0009-0006-1915-0174)
- Ghazal Sanadgol (ORCID: https://orcid.org/0000-0001-7965-1436)
- Mohammad Hosein Yazdanpanah (ORCID: https://orcid.org/0000-0003-3645-9430)
- Acile Nahlawi (ORCID: https://orcid.org/0009-0001-6128-7864)
- Leon M. Ptaszek (ORCID: https://orcid.org/0000-0003-1344-4471)
- Adham Ramadan
- Marawan Desouky
Institutions
- Boston Medical Center (US)
- Dartmouth–Hitchcock Medical Center (US)
- Salem Hospital (US)
- Massachusetts General Hospital (US)
- Mass General Brigham (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fcvm.2026.1985814
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00